News

Umicore's Strategic Vision: A Roadmap to 2028 Success

Umicore's Strategic Vision: A Roadmap to 2028 Success

Umicore's Strategic Vision: A Roadmap to 2028 Success

Today at its Capital Markets Day, the CEO of Umicore, Bart Sap, alongside the Executive Leadership Team, will share the pivotal outcomes of their Battery Materials strategy review and reveal Umicore’s roadmap guiding the company towards 2028.

Key Highlights

  • Umicore’s circular business model becomes increasingly important.
  • The mid-term plan leverages the group's strengths around four core areas: Capital, Performance, People & Culture, and Partnerships.
  • Projected capital expenditures reduced by €1.4 billion between 2025 and 2028 from previous plans, indicating a more balanced capital allocation and disciplined spending.
  • Increased focus on maximizing cash generation in core businesses while recovering value from Battery Cathode Materials.
  • A robust mid-term strategy for Battery Cathode Materials aiming at value recovery and active partnership exploration.

Mid-term Targets Explained

  • Expected adjusted EBITDA to be between €1.0 billion and €1.2 billion by 2028, with a margin exceeding 23% and return on capital employed (ROCE) exceeding 15%.
  • A cumulative free cash flow target of €1.0 to €1.2 billion during the 2025-2028 period.
  • Total investments are limited to €2.1 billion, including €1.6 billion in CapEx and about €500 million towards the IONWAY venture.

"Our circular business model is integral to our operations. Capitalizing on our expertise in metals management and materials science, we've established ourselves as industry leaders. This model underpins our strategy for battery materials, adapting to evolving market requirements," expressed Bart Sap, CEO of Umicore. "We are focused on strengthening our core businesses' cash generation capabilities while positioning Battery Cathode Materials for future value recovery by optimizing our resource management, nurturing key partnerships, and embracing a performance-driven culture."

Strategic Focus Through Key Imperatives

  • Capital: Investments will be strictly regulated, ensuring balanced distribution within the group and disciplined capital outlay.
  • Performance: Operational improvements are projected to yield savings of €100 million in adjusted EBITDA by 2025, with aims to mitigate inflationary impacts through efficiencies of at least €50 million annually from 2026 to 2028.
  • People & Culture: Umicore emphasizes fostering a culture of value and efficiency, crucial for sustaining performance improvement.
  • Partnerships: The company is actively scouting for partnerships to enhance its growth in battery materials.

Enhancing Cash Generation in Core Operations

Umicore anticipates unlocking between €2 and €2.2 billion in cumulative free cash flows from its foundational businesses through 2025-2028.

  • Catalysis: With a strong market position, this division expects revenues around €1.8 billion, aiming at a 25% adjusted EBITDA margin while targeting over €1.4 billion in free cash flow by 2028.
  • Recycling: Striving to optimize returns from existing assets while investing in future capabilities, it aims for revenues around €800 million and a significant EBITDA margin by 2028.
  • Specialty Materials: Targeting market opportunities in high-tech sectors, it expects around €600 million in revenue with robust profitability metrics.

Battery Cathode Materials and Value Recovery

Umicore has devised a strong mid-term plan for Battery Cathode Materials focused on maximizing returns and maintaining rigorous financial discipline. By reallocating investments effectively, Umicore targets:

  • Becoming adjusted EBITDA positive by 2026 and reaching positive free cash flow in 2027.
  • Generating approximately €1.1 billion in revenues by 2028.
  • Achieving an adjusted EBITDA in the region of €275 million to €325 million.
  • Maintaining an adjusted EBITDA margin exceeding 25%.
  • Having a ROCE of about 9% by 2028.

Partnership Exploration in Battery Cathode Materials

Umicore is actively seeking partnership opportunities in its battery material segment, having strategically reshaped its mid-term plan for Battery Cathode Materials. Eleven years of experience positions Umicore well for accelerating value recovery and the company remains committed to building strong customer relationships with competitive protections.

The group had its Capital Markets Day for investors and analysts earlier today. This event highlighted its vision to navigate through the complex market landscape effectively.

Frequently Asked Questions

What are the main objectives of Umicore's roadmap to 2028?

Umicore aims to strengthen its business model, maximize cash generation, and recover value in its Battery Cathode Materials segment.

How does Umicore plan to achieve cost savings?

By implementing stringent operational efficiencies and targeting gross efficiencies to offset inflation.

What investment strategies does Umicore outline for 2025-2028?

Umicore plans to limit total investments to €2.1 billion while focusing on balanced capital allocation and disciplined spending.

In which business areas is Umicore focusing its future growth?

Umicore is enhancing its foundational businesses while actively seeking partnerships within the battery materials domain.

What financial targets has Umicore set for itself by 2028?

Umicore targets an adjusted EBITDA of between €1.0 and €1.2 billion and cumulative free cash flow in the range of €1.0 to €1.2 billion.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
JOIA Rose Hall Revives Jamaican Luxury Experience

Updated Category News Views 78

A New Chapter for Jamaican Luxury If there's one thing that gets the blood pumping, it's a massive overhaul of a decades-old resort, especially one sitting pretty on Montego Bay's golden shores. December 1, 2026, marks the return of JOIA Rose Hall to the hospitality scene—shiny, revamped, and all about delivering an oasis fueled by authentic Jamaican culture. Forget...

Continue Reading
Florida's Natural, Johnsonville Settle Bet Over Juice

Updated Category News Views 63

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 30

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
Guidewire Celebrates P&C Insurance Innovators

Updated Category News Views 50

P&C Insurance Takes Center Stage If there's one thing that gets the blood pumping at a conference, it's innovation. This year, Guidewire pulled out all the stops at their Connections Conference in Las Vegas, spotlighting customer and partner triumphs in the P&C insurance sector. From Guidewire Innovation Awards to Partner Excellence Awards, the event was an ode to...

Continue Reading
Veralto Sees Strong Q3 2026 Growth, Eyes 2027 Gains

Updated Category News Views 22

Veralto's Stellar Third Quarter Performance Jumping right into the thick of it, Veralto's third quarter 2026 numbers aren't just a flash in the pan. We're talking a solid sales boost of 7.5%, reaching the magic number of $1,509 million. If you're holding NYSE:VLTO, these figures are a good look. It's not every day you see an operating profit margin hovered at an...

Continue Reading
Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

Updated Category News Views 48

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Continue Reading
Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

Updated Category News Views 57

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Continue Reading
Domestic Violence Laws: A Broken Shield Revealed

Updated Category News Views 24

A Look at Where Policies Stumble Life's got no script for chaos, and you'd think the laws meant to protect folks from domestic violence would at least have a solid plan. Turns out, that's not always the case. Bloomberg Law just pulled back the curtain in a stinging investigation that exposes the gaping holes in these well-meaning policies. Why spill my morning coffee over...

Continue Reading
Quaker Houghton Propels Forward with Q3 2026 Gains

Updated Category News Views 28

Quaker Houghton's Strategy Yields Positive Q3 2026 Results Imagine getting through another quarter against global economic headwinds and coming out profitable. That’s exactly what Quaker Houghton (NYSE:KWR) pulled off in Q3 2026. Their net sales jumped to a solid $544.5 million, marking a 10% increase from the same quarter last year. Not bad for a company that had its...

Continue Reading

Top 5 Most Recently Viewed Articles

Medtronic's Sphere-360™ Catheter Receives CE Mark and US IDE Milestones

Updated Category News Views 160

Medtronic Achieves Major Milestones with Sphere-360™ Catheter In a significant development for the treatment of atrial fibrillation, Medtronic plc (NYSE: MDT) announced the receipt of the CE Mark for its Sphere-360™ single-shot pulsed field ablation (PFA) catheter. This innovative device is specifically designed to treat paroxysmal atrial fibrillation (AFib)...

Continue Reading
Oculis Holding AG Announces Participation in Investor Events

Updated Category News Views 178

Oculis Holding AG Engaging with Investors at Conferences Based in Switzerland, Oculis Holding AG (Nasdaq: OCS; Iceland: OCS) is a trailblazer in the biopharmaceutical industry, dedicated to pioneering treatments for ophthalmic and neuro-ophthalmic conditions. Today, Oculis is eager to convey its latest advancements at several prestigious upcoming investor conferences,...

Continue Reading
Freshpet CEO Implements Strategic Trading Plan for Shares

Updated Category News Views 159

Freshpet's Leadership Takes Initiative with Trading Plans Freshpet, Inc. (NASDAQ: FRPT), a leading name in fresh pet food, is making headlines as its Chief Executive Officer, Billy Cyr, shares his plans to adopt a Rule 10b5-1 trading strategy. This proactive approach is designed for the exercise of stock options that were granted back in 2016, with a looming expiration on...

Continue Reading
NOMAD Power Steps Into AI Energy Arena with Ticker NMAD

Updated Category News Views 14

From Reagents to Railways: The NOMAD Transformation Jumping straight from the lab to the electric grid, former biotech player LIXTE Biotechnology Holdings, Inc. has completed a dramatic pivot, emerging as NOMAD Power Solutions, Inc. (NASDAQ: NMAD). This isn't your everyday ticker change—it's a full-fledged identity overhaul that repositions them smack in the midst of AI...

Continue Reading
Novaturas Reports 2024 Half-Year Financial Performance

Updated Category News Views 93

Novaturas Reveals Half-Year Financial Results for 2024 On August 23, Kristijonas Kaikaris, the CEO of AB “Novaturas,” along with Interim CFO Auks? Kriau?i?nait?, presented the company's consolidated financial results for the first half of 2024 to investors. This report highlights the key financial indicators for Novaturas Group and its operations during this time...

Continue Reading